Advances and perspectives of PARP inhibitors
Abstract DNA damage repair deficiency leads to the increased risk of genome instability and oncogenic transformation. In the meanwhile, this deficiency could be exploited for cancer treatment by inducing excessive genome instability and catastrophic DNA damage. Continuous DNA replication in cancer c...
Main Authors: | Ming Yi, Bing Dong, Shuang Qin, Qian Chu, Kongming Wu, Suxia Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Experimental Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40164-019-0154-9 |
Similar Items
-
PARP inhibitor resistance: the underlying mechanisms and clinical implications
by: He Li, et al.
Published: (2020-06-01) -
PARP inhibitors in cancer therapy: Magic bullets but moving targets
by: Girish M. Shah, et al.
Published: (2013-11-01) -
Advances in using PARP inhibitors to treat cancer
by: Kummar Shivaani, et al.
Published: (2012-03-01) -
New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
by: Ye Han, et al.
Published: (2020-11-01) -
Resistance to PARP-inhibitors in Cancer Therapy
by: Alicia eMontoni, et al.
Published: (2013-02-01)